Becker and The Institute of Internal Auditors are partnering to develop a new Certified Internal Auditor Exam Review to launch in March 2025.

NEW YORK, NY/ ACCESSWIRE/ September 26, 2023/ Today, Protagenic Therapeutics, Inc., a pioneering biopharmaceutical company, has announced the commencement of its Phase I/IIa clinical trial for ...

The Phase IIa clinical trial is open-label study evaluating Namodenoson in patients with advanced pancreatic adenocarcinoma whose disease has progressed following at least one prior line of ...

Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 (10 evaluable) patients with advanced Soft Tissue Sarcoma (STS).